In the News

NIH Funding Opportunity: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21)

Admin • CCON • 11/17/2015

This Funding Opportunity Announcement (FOA) encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. The primary intent is to... Read more »

Read More...

AHA: Candesartan May Preserve Cardiac Function in Breast Ca Patients

Admin • CCON • 11/11/2015

ORLANDO — An angiotensin II receptor blocker may help to preserve cardiac function in patients receiving treatment for breast cancer, according to results of a small trial reported here. Read... Read more »

Read More...

Heart drugs during breast cancer treatment can help women avoid cardiac issues

Admin • CCON • 11/11/2015

ORLANDO, Fla. — Many cancer treatments have a dark side — they can damage the heart. New research suggests this risk might be lowered in women with breast tumors if... Read more »

Read More...

Lee Memorial collaborative focuses on cancer, heart disease

Admin • CCON • 11/9/2015

Most of us know heart disease is the No. 1 killer of Americans, followed closely by cancer. It is a lesser known fact that cancer therapy can cause adverse effects on... Read more »

Read More...

Cardiotoxicity Low for Patients Receiving Paclitaxel, Trastuzumab for ERBB2+ Breast Cancer

Admin • CCON • 11/6/2015

Cardiac toxic effects from paclitaxel with trastuzumab, presenting as grade 3 or 4 left ventricular systolic dysfunction (LVSD) or asymptomatic left ventricular ejection fraction decline (LVEF), were low in patients... Read more »

Read More...

The Connection Between Cancer Treatment and Cardiac Problems

Admin • CCON • 10/20/2015

When she was just a year old, Brenda Yano was diagnosed with acute leukemia. She was one of the lucky ones, cured by aggressive chemotherapy. Years later, Yano was told... Read more »

Read More...

Apply Today! Fellowship in “Cardiotoxcity Prevention” – Peter Munk Cardiac Center, Toronto General Hospital, UHN

Admin • CCON • 4/20/2015

The Ted Rogers Program in Cardiotoxicity Prevention at the Peter Munk Center will be offering a formal clinical / research fellowship in advanced heart failure and cardiotoxicity prevention starting July... Read more »

Read More...

Apply Today! Cardio-Oncology Fellowship Program

Admin • CCON • 2/2/2015

Two Cardio-Oncology Fellowship positions are available for the 2015-2016 academic year at both the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, PA, and at the University of... Read more »

Read More...

Exercise Prescription During Cancer Treatment

Admin • CCON • 7/17/2014

Amy Kirkham is a PhD Candidate at University of British Columbia specializing in cardiovascular and exercise oncology. Her research involves the use of exercise during and after cancer treatment, including... Read more »

Read More...

OCOP featured in The CV Edge May issue

Admin • CCON • 6/23/2014

The CV Edge May 2014 issue Recently, OCOP (Ottawa Cardiac Oncology Program) was featured in the May 2014 issue of CV Edge, created by CACPR (Canadian Association of Cardiovascular Prevention... Read more »

Read More...